. A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis.
IB-MECA significantly reduced mortality in mice lacking the A 1AR or A 2aAR but not the A3AR, demonstrating specificity of IB-MECA in activating A3ARs and mediating protection against sepsis-induced mortality. We conclude that endogenous or exogenous A3AR activation confers significant protection from murine septic peritonitis primarily by attenuating the hyperacute inflammatory response in sepsis.
acute renal failure; inflammation; multiorgan injury; survival SEPSIS REPRESENTS A MAJOR clinical problem without effective therapy. Despite advances in antibiotic, hemodynamic, and ventilatory support, the incidence of sepsis and the number of sepsisrelated deaths is very high. Approximately 750,000 annual cases of severe sepsis occur in the United States leading to 215,000 deaths (9.3% of deaths from all causes) (3, 11, 34) . Although the pathogenesis of sepsis-induced multiorgan injury leading to death is incompletely understood, the initial hyperinflammatory process and subsequent hypoimmune phase contribute to mortality and morbidity in sepsis. The initial hyperinflammatory response seen in sepsis is associated with uncontrolled, hyperexuberant cytokine production that can be deleterious to various tissues and leads to organ injury and dysfunction. After this hyperinflammatory phase, a hypoimmune phase ensues with enhanced apoptotic cell death occurring in multiple organs including the spleen, kidney, liver, and heart (23, 24) .
Adenosine receptors (ARs) modulate inflammation and cell death in many organs including the heart, kidney, lung, and liver, and these organs are subject to multiorgan injury in sepsis (17, 26, 29, 42) . We have demonstrated that ARs play important roles in modulating outcome after renal ischemia and reperfusion injury, as well as after cecal ligation and puncture (CLP)-induced sepsis, in part by modulating inflammation (17, 28 -31) . A 3 ARs in particular appear to have a complex role in inflammation as both proinflammatory and anti-inflammatory effects have been demonstrated (15, 46, 51) . We have previously shown that A 3 AR activation before renal ischemia results in the worsening of renal function and that mice lacking A 3 ARs displayed improved renal function after ischemia reperfusion injury (30) . In contrast, a selective A 3 AR agonist N 6 -(3-iodobenzyl)ADO-5ЈN-methyluronamide (IB-MECA) reduced inflammation in mouse models of colitis and reduced LPS-induced mortality in mice (19, 32) . However, Sullivan et al. (49) speculated that the protective effects of IB-MECA against endotoxemia may actually be mediated by A 2a ARs because high doses of IB-MECA may activate both A 2a ARs and A 3 ARs. Therefore, the role of A 3 ARs in protecting against sepsis and inflammation is not clear. In addition, the role of A 3 ARs in CLP-induced sepsis has never been studied. In the present study, we tested the effects of a selective A 3 AR agonist (IB-MECA) against CLP-induced sepsis, a better model of sepsis than the endotoxin model of sepsis. We determined the effects of genetic deletion of A 3 ARs on sepsis-induced mortality and hepatic and renal dysfunction by subjecting A 3 AR knockout (KO) mice to CLP sepsis. We also tested the effects of IB-MECA in mice genetically lacking the A 1 AR or A 2a AR to determine the specificity of IB-MECA activating A 3 ARs in mediating protection from sepsis.
MATERIALS AND METHODS

AR KO Mice
All animal protocols were approved by the Institutional Animal Care and Use Committee of Columbia University (New York, NY). The generation and initial characterization of the congenic A 3AR KO mice on a C57BL/6 background have been described previously (50) and were provided by Dr. Marlene Jacobson (Department of Neuroscience, Merck Research Laboratories, West Point, PA). The congenic A 2aAR KO line on a C57BL/6 background was generated as described previously (7) and provided by Jiang-Fan Chen and Michael Schwarzschild (Department of Neurology, Boston University, Boston, MA). Commercial male C57BL/6 mice (Taconic Farms, Germantown, NY) served as wild-type (WT) controls. Male and female C57 mice are known to have different outcomes following CLP sepsis (2); therefore, only male mice were used in this study. The A 3AR KO mice have been shown to have equivalent blood pressure and heart rates compared with WT mice (46) . In addition, A 3AR KO mice have equivalent mRNA expression of A 1, A2a, and A2b ARs compared with WT mice as reported by Salvatore et al. (46) and confirmed by us (data not shown). Breeding pairs of A 1AR heterozygous mice were obtained from Dr. Jurgen Schnermann (National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health) to generate A 1AR WT and A1AR KO mice as described previously (31) .
Induction of Sepsis by CLP
Mice were anesthetized with intraperitoneal pentobarbital (50 mg/kg or to effect) and were allowed to spontaneously breathe room air on an electric heating pad under a warming light. CLP was performed as described previously (16) . Briefly, the cecum was isolated through a small midline incision and the distal (0.5 cm) portion of the cecum below the ileocecal valve (to avoid bowel obstruction) was ligated with a 4.0 silk suture. The cecum was punctured through the surface and then along its antimesenteric border (double puncture) with a 22-or 20-gauge needle and a small amount of stool was extruded through the puncture site. We determined in our preliminary studies that the needle size had a significant impact on mortality and hepatic/renal dysfunction after cecal puncture. Since the peritoneal surface is an excellent conduit for absorption, instillation of 0.5 cc normal saline into the peritoneal cavity was performed for fluid resuscitation before closing the abdomen. Fluid resuscitation was continued during the initial 24 h following CLP, by administering subcutaneous saline (1 cc every 8 h for 24 h). Twenty-four or 48 h after CLP, some mice were killed with an overdose of intraperitoneal pentobarbital, and plasma and kidneys were collected.
Survival Studies
To determine 7-day survival, male A 3AR WT mice (n ϭ 32 for 20-gauge and n ϭ 21 for 22-gauge needle) and A3KO (n ϭ 35 for 20-gauge and n ϭ 23 for 22-gauge needle) mice were subjected to CLP. All mice had free access to water and food and were observed by dedicated research personnel to determine 7-day survival. All severely moribund animals were euthanized with an overdose injection of anesthetic in adherence with our animal care protocol. This euthanasia was blinded, and the moribund animals were counted in the mortality curve. To examine whether pharmacological blockade of endogenous A 3AR could exert an impact on survival, A3AR WT mice (n ϭ 12 for 20-gauge and n ϭ 11 for 22-gauge needle, respectively) received a subcutaneous injection (1 mg/kg) of 3-ethyl-5-benzyl-2-methyl-4-phenylethynyl-6-phenyl-1,4-(Ϯ)-dihydropyridine-3,5-dicarboxylate (MRS-1191; a selective A 3AR antagonist), 20 min prior and 6 h following CLP. To determine whether pharmacological stimulation of endogenous A 3AR could exert an impact on survival, A3AR WT (n ϭ 20 and 16 for 20-and 22-gauge needle, respectively) mice received a subcutaneous injection (0.5 mg/kg) of N 6 -(3-iodobenzyl)ADO-5ЈN-methyluronamide (IB-MECA, a selective A3AR agonist), 20 min before CLP. To determine whether multiple injections were superior to a single injection, some A3AR WT mice (n ϭ 20 and 12 for 20-and 22-gauge needle, respectively) received additional injections of 0.5 mg/kg IB-MECA 4 and 18 h after CLP. We also treated A1AR KO (n ϭ 12), A2aAR KO (n ϭ 10), and A3AR KO mice (n ϭ 10) with either a single dose or multiple doses of IB-MECA and subjected them to 20-gauge CLP sepsis to evaluate the selectivity of IB-MECA for the A3AR.
Assessment of Renal Function and Hepatic Injury After Sepsis
Renal function was assessed by measuring plasma creatinine 24 and 48 h after CLP by a colorimetric method based on the Jaffee reaction (21) . Hepatic injury 24 and 48 h after CLP was assessed by measuring plasma aspartate aminotransferase (AST) and alanine aminotransferase (ALT) using a commercially available colorimetric method (Sigma, St. Louis, MO). Renal and hepatic function at 48 h after CLP were measured for 22-gauge CLP animals only as 20-gauge CLP animals showed severe 24 h mortality: ϳ50% for A 3AR WT mice and Ͼ80% for A3AR KO mice.
Measurement of Blood and Peritoneal Bacterial Load
Bacterial counts were performed on aseptically harvested blood and peritoneal fluid samples. Blood was aseptically obtained by cardiac puncture. Sterile saline (3 ml) was injected into the peritoneal cavity after aseptic preparation of the abdominal wall, and peritoneal fluid was obtained by aspiration. Samples were serially diluted in sterile saline and cultured on tryptic soy agar plates (Fisher Scientific). Plates were incubated (37°C) for 48 h, and colony counts were performed by an operator blinded to the different treatment groups. Results are expressed as colony-forming units per milliliter.
Measurement of Systemic Cytokines by ELISA
Murine plasma TNF-␣ (ALPCO, Windham, NH), keratinocytederived chemokine (KC; R&D Systems, Minneapolis, MN), and IL-6 and IL-10 (eBiosciences, San Diego, CA) concentrations were measured using commercially available ELISA kits according to the manufacturer's instructions from plasma taken 24 h after CLP.
Assessment of Renal Inflammation
MPO activity. Renal inflammation 24 h after CLP was assessed by measurement of renal MPO activity (marker of leukocyte infiltration) as described previously (31) . Renal cortex (ϳ200 mg) was dissected and homogenized for 30 s in 2 ml of 50 mM potassium phosphate buffer, pH 7.4, at 4°C. The samples were centrifuged for 15 min at 16,000 g at 4°C, and the resultant pellet was resuspended in 2 ml of 50 mM potassium phosphate buffer, pH 7.4, with 0.5% hexadecyltrimethyl ammonium bromide at 4°C. The samples were sonicated for 30 s and centrifuged at 16,000 g for 15 min at 4°C. Fifty microliters of supernatant were mixed with 750 l of 45 mM potassium phosphate buffer, pH 6.0, containing 0.167 mg/ml o-dianisidine and 0.3% H 2O2. Absorbance (460 nm) was measured over a period of 5 min (unit of enzyme activity ϭ ⌬OD⅐min Ϫ1 ⅐mg protein
Ϫ1
), and the relative MPO activity was expressed as the percentage of the sham-operated group. The remaining supernatant was used to determine protein concentrations.
Semiquantitative RT-PCR for proinflammatory cytokines. Twentyfour hours after CLP, renal corticomedullary expression of mRNAs encoding proinflammatory markers were also determined by using semiquantitative RT-PCR as described previously (31) . Renal cortices were dissected, total RNA was extracted by using Trizol (Invitrogen, Carlsbad, CA) reagent, and RNA concentrations were determined with spectrophotometric readings at 260 nm. RT-PCR was performed to analyze the expression of proinflammatory [KC, macrophage inflammatory protein 2 (MIP-2), monocyte chemoattractive protein -1 (MCP-1), ICAM-1, IL-1␤, and TNF-␣] genes. Primers were designed based on published GenBank sequences for mice (Table 1) . Primer pairs were chosen to yield expected PCR products of 200 -600 bp and to amplify a genomic region that spans one or two introns to eliminate the confounding effect of amplifying contaminating genomic DNA. RT-PCR was performed using the Access RT-PCR System (Promega), which is designed for a single tube reaction for first-strand cDNA synthesis (48°C for 45 min) using AMV reverse transcriptase, and subsequent PCR using Tfl DNA polymerase. PCR cycles included a denaturation step of 94°C for 30 s, followed by an optimized annealing temperature (Table 1 ) for 1 min, followed by a 1-min extension period at 68°C. All PCR reactions were completed with a 7-min incubation at 68°C to allow enzymatic completion of incomplete cDNAs. The PCR cycle number for each primer pair was optimized to yield linear increases in the densitometric measurements of resulting bands with increasing cycles of PCR (15-26 cycles, Table 1 ). The starting amount of RNA was also optimized to yield linear increases in the densitometric measurements of resulting bands at an established number of PCR cycles. For each experiment, we also performed semiquantitative RT-PCR under conditions yielding linear results for GAPDH (15 cycles) to confirm equal RNA input. Five microliters of the RT-PCR product was analyzed on a 6% acrylamide gel stained with SYBR Green (Invitrogen, Carlsbad, CA) for analysis with a UVP Bio-imaging System (Upland, CA). Semiquantitative analysis of mRNA expression was accomplished by obtaining the ratio of the band density of the mRNAs of interest to that of GAPDH (a housekeeping gene) from the same sample. Because samples were run on multiple gels (e.g., control samples were run on 3 separate gels, n ϭ 2 each to make the total n ϭ 6), there were inter-assay variations requiring normalization. Band intensity quantifications of the control group (sham group) between one gel and another can vary (e.g., due to staining differences). Therefore, the data presented are actually the normalized values of cytokine mRNA/GAPDH ratio to the sham A 3AR WT group in each gel. These ratios are presented in the figure with the sham animals normalized to one.
Immunohistochemistry
Paraffin-embedded mouse kidney sections were deparaffinized in xylene and rehydrated through graded ethanols to water. After blocking with 10% normal horse serum/PBS solution, the slides were incubated overnight with primary antibody MAC-2 (Cedarlane Labs, Burlington, NC), neutrophils (cat. no. MCA771G; Serotec, Raleigh, NC), and Tlymphocytes (CD3, pan T cell marker; Serotec) at 4°C in a humidified chamber. Endogenous alkaline phosphatase activity was blocked with 1% levamisole. The primary antibody was localized by using the Vectastain ABC-Alkaline Phosphtase detection system using 5-Bromo-4-chloro-3Ј-indolyphosphate-p-toluidine salt/NitroBlue tetrazolium chloride (BCIP/ NBT) as substrate (Vector Laboratories, Burlingame, CA). Control serum IgG was used for negative isotype control experiments.
Assessment of Renal NF-B Activation
NF-B activation is associated with transcription pathways of proinflammatory mediators, and suppression of NF-B activity improves outcome of proinflammatory injuries, such as ischemia reperfusion injury and arthritis (6, 35) . Renal cortices were dissected and immersed in 500 l of buffer A [10 mM HEPES pH 7.9, 10 mM KCL, 1.5 mM MgCl 2, 20% glycerol, 0.2 mM PMSF, 0.5 mM DTT, protease inhibitor cocktail (Mini-complete-EDTA; Roche, Indianapolis, IN)] for 10 min at 4°C. The cells were homogenized using a polytron homogenizer for 5 s to release the nuclei into solution, and centrifuged at 18,000 g for 5 min at 4°C. The supernatant was discarded and the pellet resuspended in 50 l of buffer B (20 mM HEPES pH 7.9, 1.5 mM MgCl 2, 0.5 mM EDTA, 25% glycerol, 0.1% Triton X-100, 0.2 mM PMSF, 0.5 mM DTT, protease inhibitor cocktail), and incubated for 1 h at 4°C with occasional swirling to extract nuclear protein. The nuclei were centrifuged at 16,000 g for 15 min, and the supernatant containing nuclear protein was used for EMSA for NF-B.
EMSA was performed using the Gel Shift Assay Systems (Promega, Madison, WI). The oligonucleotides for NF-B (Promega) consensus sequences were end-labeled with 10 Ci of [␥-32 P]ATP (PerkinElmer Life Technology, Wellesley, MA) and purified by using a G-25 spin column (Amersham Biosciences, Piscataway, NJ). Ten micrograms of the nuclear extract were incubated with 1 l of the labeled probe for 20 min at room temperature and electrophoresed on a 4% polyacrylamide gel (200 V at 4°C). Two micrograms of Hela cell nuclear extract (Promega) was used for a positive control and 1 l of NF-B p65 TransCruz polyclonal antibody (Santa Cruz Biotechnology, CA) was coincubated with the nuclear protein and probe for a supershift reaction. One hundred-fold concentration of unlabeled probe was coincubated as a competitor in a negative control reaction. In addition to the protein assay, we performed immunoblotting for histones to verify equal loading of nuclear fractions (data not shown). The gel was then transferred to blotting paper and exposed to film or scanned with a Phospho Imager (Molecular Dynamics, Piscataway, NJ).
Statistical Analysis
A one-way analysis of variance was used to compare mean values across multiple treatment groups with a Dunnett's post hoc multiple comparison test (e.g., sham vs. CLP). Survival statistics were compared with a Kaplan-Meier curve and log rank test. In all cases, a P Ͻ 0.05 was taken to indicate significance.
Protein determination. Protein content was determined with the Pierce (Rockford, IL) bicinchoninic acid protein assay reagent using bovine serum albumin as a standard.
RESULTS
Endogenous or Exogenous A 3 AR Activation Protects Against CLP-Induced Mortality
We initially measured the effect of endogenous A 3 AR activation on mortality from CLP-induced septic peritonitis by Respective anticipated RT-PCR product size, PCR cycle number for linear amplification, and annealing temperatures used for each primer are also provided. KC, keratinocyte-derived chemokine; MIP-2, macrophage inflammatory protein 2, MCP-1, monocyte chemoattractant protein 1; IP-10, interferon-induced protein 10, RANTES, regulated upon activation normal T-cell expressed and secreted. comparing 7-day survival for A 3 AR WT and A 3 AR KO mice. As demonstrated in Fig. 1, A and B, mice lacking endogenous A 3 ARs had significantly higher mortality rates compared with A 3 AR WT mice after CLP sepsis induced with either a 20-gauge ( Fig. 1A , P Ͻ 0.05) or a 22-gauge (Fig. 1B , P Ͻ 0.01) needle. At 24 h following CLP with a 22-or 20-gauge needle, the mortality rate for the A 3 AR KO mice was 31.3% and 80% compared with 9.5% and 48.6% in A 3 AR WT mice, respectively. At 7 days, the 22-gauge needle-induced mortality rate for A 3 AR KO mice was 95.7% compared with 33.3% in A 3 AR WT mice. Log rank analysis of the survival statistics revealed significant differences between A 3 AR WT and A 3 AR KO mice after CLP sepsis induced with a 20-gauge (P Ͻ 0.05) or a 22-gauge (P Ͻ 0.01) needle.
Selective antagonism of A 3 AR with MRS-1191 resulted in significantly worse mortality in A 3 AR WT mice after CLP sepsis induced with either the 22-or 20-gauge needle (Fig. 1,   A and B) mimicking the decreased survival observed with A 3 AR KO mice. At 24 h following CLP with a 22-or 20-gauge needle, the mortality rate for A 3 AR WT mice treated with MRS-1191 was 36.4% and 70% compared with 9.5 and 48.6% in untreated A 3 AR WT mice, respectively (P Ͻ 0.05). At 7 days, 22-gauge needle-induced mortality rate for the A 3 AR WT mice treated with MRS-1191 was 81.8% compared with 33.3% in A 3 AR WT mice (P Ͻ 0.05).
A single injection of IB-MECA (a selective agonist for A 3 ARs, 0.5 mg/kg) resulted in significantly better initial survival in A 3 AR WT mice after CLP sepsis induced with either a 22-or 20-gauge needle (Fig. 1, A and B) . At 24 h following CLP with a 22-or 22-gauge needle, the mortality rate for A 3 AR WT mice treated with IB-MECA was 0% and 31.3% compared with 9.5% and 48.6% in untreated A 3 AR WT mice, respectively (P Ͻ 0.05). However, the survival at day 7 did not differ between mice injected with a single dose of IB-MECA and vehicle-treated mice (Fig. 1, A and B) . When we gave an additional IB-MECA treatment at 4 and 18 h after CLP, the 7-day survival was significantly better in WT mice. At 7 days following CLP with a 22-or 22-gauge needle, the mortality rate for A 3 AR WT mice treated with IB-MECA was 10 and 60% compared with 33 and 100% in untreated A 3 AR WT mice, respectively (P Ͻ 0.05).
We wanted to determine whether protection against mortality induced by CLP sepsis with IB-MECA is truly independent of A 1 ARs and A 2a ARs. Sullivan et al. (49) proposed that IB-MECA-induced protection against endotoxemia may be mediated by A 2a ARs because IB-MECA may activate A 2a ARs at high doses on the basis of their in vitro binding data (19) . Therefore, we treated mice lacking A 1 AR, A 2a AR, or A 3 AR with IB-MECA (0.5 mg/kg) and determined a 7-day survival after 20-gauge CLP sepsis. . Surprisingly, the 7-day survival of A 2a AR KO mice (10%) after 20-gauge CLP sepsis was slightly, but significantly (P ϭ 0.0342) better than the survival of A 2a AR WT mice (0%). The A 3 AR KO mice were not protected against CLP sepsis with IB-MECA (Fig. 1) . (Table 2 ). However, A 3 AR KO mice showed significantly worse renal dysfunction and hepatic injury compared with A 3 AR WT at 24 h after CLP ( Table 2 ). Treatment of A 3 AR WT mice with an A 3 AR agonist (IB-MECA) or antagonist (MRS-1191) improved or worsened renal dysfunction and hepatic injury 24 h after CLP sepsis, respectively ( Table 2) . Forty-eight hours after CLP, plasma creatinine and ALT improved in all groups to normal levels (Table 2) . However, plasma AST levels at 48 h after CLP were significantly higher for A 3 AR KO mice and significantly lower for A 3 AR WT mice treated with IB-MECA compared with A 3 AR WT mice ( Table 2) .
Modulation of Hepatic and Renal Dysfunction After
Modulation of Plasma Proinflammatory and AntiInflammatory Cytokine Levels After CLP Sepsis with A 3 AR Deletion
With ELISA, TNF-␣, KC, IL-6, and IL-10, plasma levels were determined 24 h following CLP-induced sepsis. TNF-␣ and KC plasma levels in mice subjected to 22-or 20-gauge CLP sepsis were elevated above normal baseline values (TNF-␣: Ͻ18.2 pg/ml and KC: 167 Ϯ 23 pg/ml, n ϭ 4). However, A 3 AR KO mice showed significantly elevated TNF-␣ and KC plasma levels compared with A 3 AR WT mice 24 h after the induction of sepsis (Table 2) . Plasma IL-6 levels increased in mice subjected to 22-and 20-gauge CLP sepsis with more severe sepsis (20-gauge CLP) leading to higher IL-6 levels ( Table 2 ). Plasma levels of anti-inflammatory IL-10 levels also increased in mice subjected to 22-or 20-gauge CLP sepsis with A3AR KO mice demonstrating significantly higher IL-10 levels compared with A 3 AR WT mice ( Table 2) .
Modulation of Renal MPO Activity After CLP Sepsis with A 3 AR Deletion or Activation
MPO is an enzyme present in leukocytes and is an index of tissue leukocyte infiltration following injury (53) . Since activated leukocyte infiltration is a hallmark of acute inflammation, we sought to determine the effect of endogenous or exogenous A 3 AR activation on renal MPO activity 24 h following CLP-induced sepsis. Mice lacking endogenous A 3 ARs subjected to 20-gauge CLP showed significantly higher MPO activity than A 3 AR WT mice subjected to 20-gauge CLP (Table 2 ). In addition, activation of A 3 ARs with IB-MECA reduced the MPO activity in A 3 AR WT mice after CLP sepsis ( ⌬OD/mg protein, n ϭ 5, and Sham A 3 AR WT mice MPO activity ϭ 0.05 Ϯ 0.03 ⌬OD/mg protein, n ϭ 5).
Modulation of Renal mRNA Expression of Proinflammatory Markers Following CLP Sepsis with A 3 AR Deletion or Activation
We next examined the effects of endogenous A 3 AR activation on mRNA expression in renal cortices following CLPinduced sepsis. A 3 AR KO (n ϭ 4) and WT (n ϭ 4) mice had similar levels of mRNA encoding KC, IL-1␤, TNF-␣, ICAM-1, MCP-1, and MIP-2 24 h following sham operation (Fig. 3) . In contrast, A 3 AR KO (n ϭ 6) mice demonstrated increased mRNA expression of these proinflammatory mRNA levels compared with A 3 AR WT (n ϭ 6) mice 24 h after the induction of sepsis (Fig. 3) . In addition, activation of A 3 ARs with IB-MECA reduced proinflammatory mRNA levels in A 3 AR WT mice after CLP sepsis (Fig. 3) .
Immunohistochemistry
Immunohistochemistry for three leukocyte subtypes (neutrophils, T-lymphocytes and macrophages) in kidneys of WT and A 3 AR KO mice subjected to CLP showed that very few (1-2 cells per field of ϫ400) neutrophils and lymphocytes infiltrate the kidney 6 -48 h after CLP. Slightly increased macrophage infiltration (including resident macrophages) was observed for both WT and A 3 AR KO mice; however, there were no quantitative differences between the two groups of mice (data not shown).
A 3 AR Activation Reduces and A 3 AR Deletion Increases CLPInduced NF-B Nuclear Translocation After Sepsis
Renal cortices isolated from A 3 AR WT (n ϭ 4) or A 3 AR KO (n ϭ 5) mice had similar levels NF-B nuclear translocation 24 h following sham operation (Fig. 4) . In contrast, renal cortices from A 3 AR KO (n ϭ 6) mice exhibit increased NF-B nuclear translocation 24 h following the induction of sepsis compared with cortices isolated from A 3 AR WT mice (n ϭ 6, Fig. 4 ). In contrast, renal cortices from A 3 AR WT mice treated with IB-MECA (n ϭ 6) show reduced NF-B nuclear translocation 24 h following the induction of sepsis compared with cortices isolated from A 3 AR WT mice subjected to CLP sepsis. The NF-B-specific band supershifted with a p65 antibody (data not shown).
Bacterial Counts in Blood and Peritoneal Fluid After CLP Sepsis
Aerobic bacteria in blood and peritoneal fluid were counted 24 h after CLP in A 3 AR WT mice (n ϭ 8 for 22-gauge and n ϭ 7 for 20-gauge), A 3 AR KO mice (n ϭ 6 for 22-gauge and n ϭ 6 for 20-gauge) and A 3 AR WT mice treated with 0.5 mg/kg IB-MECA (n ϭ 7 for 22-gauge and n ϭ 6 for 20-gauge). The average bacterial counts in blood did not differ between A 3 AR WT mice, A 3 AR KO mice and A 3 AR WT mice treated with 0.5 mg/kg IB-MECA subjected to either 22-or 20-gauge needle (Fig. 5A) . In contrast, the average aerobic bacterial count in the peritoneal fluid was significantly higher for A 3 AR KO mice compared with A 3 WT mice subjected to 22-gauge needle (Fig. 5B) . The average peritoneal bacterial counts for mice subjected to more severe sepsis with 20-gauge needle did not differ between A 3 AR WT mice, A 3 AR KO mice, and A 3 AR WT mice treated with 0.5 mg/kg IB-MECA (Fig. 5B) .
DISCUSSION
The major finding of the present study is that exogenous A 3 AR activation reduced mortality and improved renal and hepatic function after CLP-induced sepsis. Improved survival 29Ϯ4 (4) 28Ϯ5 (4) 22Ϯ4 (4) 20 (24 h) 142Ϯ10 (12) 184Ϯ21 (7) (6) 2006Ϯ382 (6) 2212Ϯ469 (6) 20 (24 h) 4135Ϯ1122 (5) 3896Ϯ1127 (5) 4997Ϯ1161 (5) IL-10 ELISA, pg/ml 22 (24 h) 4483Ϯ573 (7) 8632Ϯ1195 (6)* 5170Ϯ605 (6) 20 (24 h) 4506Ϯ497 (7) 9683Ϯ664 (5) and organ function with A 3 AR activation was associated with reduced inflammation. Moreover, mice lacking endogenous A 3 ARs and mice treated with a selective A 3 AR antagonist demonstrated increased mortality, increased acute renal and hepatic injury, and increased inflammation associated with murine septic peritonitis. Importantly, the A 3 AR agonist IB-MECA protected against CLP-sepsis in A 1 KO and A 2a KO mice without protecting the A 3 KO mice, ruling out the in- Our previous studies (16, 17) , as well as studies by others (10, 18, 23, 35, 47) , demonstrate that modulation of the hyperactive inflammatory response after CLP sepsis can improve outcome. The role of A 3 ARs in the modulation of inflammation is complicated by seemingly conflicting reports. A 3 AR activation can produce proinflammatory or anti-inflammatory states depending on the cell type and the organs studied. For example, A 3 ARs in murine mast cells contribute to the inflammatory changes in the lung (52) . In addition, antigendependent degranulation of bone marrow-derived mast cells are mediated by A 3 ARs (43, 46) . We have previously demonstrated that A 3 AR activation exacerbates renal dysfunction and mice lacking A 3 ARs had better renal function following renal ischemia reperfusion injury (30) . On the other hand, A 3 AR agonists inhibit LPS-mediated release of TNF-␣ in vivo and in vitro in macrophage cultures (37, 46) . More importantly, the A 3 AR agonist IB-MECA reduces mortality after endotoxin treatment in mice (19) . Other investigators demonstrated reduced inflammation and increased survival with activation of A 3 ARs in two murine models of colitis (32) .
However, Sullivan et al. (49) suggested that the protective effects of IB-MECA may be due to the activation of A 2a ARs as In fact, our study demonstrated that the A 2a KO mice had slightly, but significantly, improved 7-day survival after 20-gauge CLP. This was a surprising finding as it is well known that the A 2a AR activation reduces inflammation and improves outcome in many disease models including ischemia and reperfusion injury of the kidney (39, 40) and liver (9) , as well as LPS-induced endotoxemia (49) . Our finding is consistent with the recently published work of Nemeth et al. (38) . In their study, mice lacking the A 2a AR (from a CD-1 background) as well as antagonism of A 2a AR showed improved outcome after CLP sepsis.
The effect of endogenous or exogenous A 3 AR activation in sepsis is measured in this study by tracking animal survival and by assessing kidney and liver dysfunction. In this study, we demonstrate a cytoprotective role of A 3 AR in sepsis because A 3 KO mice had worse survival and renal/hepatic dysfunction after sepsis. Moreover, even a single injection of an A 3 AR agonist at the onset of 22-or 20-gauge needle puncture CLP sepsis protected against sepsis-induced early mortality and organ dysfunction. However, a single IB-MECA injection resulted in equivalent 7-day mortality. Multiple injections of IB-MECA resulted in drastic improvement of 7-day survival. In addition, the A 3 AR antagonist MRS-1191 equalized A 3 AR WT survival with A 3 AR KO survival. The protective role of A 3 ARs in CLP-induced sepsis is in stark contrast to their detrimental role in other forms of acute renal failure including ischemia and reperfusion injury and glycerol-induced myoglobinuria, indicating fundamental differences in the mechanisms of pathogenesis of ARF due to sepsis and isolated renal ischemia and reperfusion injury (30) .
The genetic background of mice has been shown to be an important factor in outcome after several types of injury including sepsis, inflammation, and ischemia and reperfusion (4, 10, 36) . A 2a AR KO and the A 3 AR KO mice used in this study are congenic on a C57BL/6 background with more than 12 backcrossings. We therefore used commercially available C57BL/6 mice as their WT controls. The A 1 AR KO mice are not congenic and therefore, WT littermates were used as controls of the A 1 AR KO mice. We note significant differences in the survival rates between A 1 AR WT mice (noncongenic) and C57BL/6 mice (congenic WT mice for A 2a AR KO and A 3 AR KO mice) after equivalent degrees of CLP sepsis. Our data further provide evidence that the genetic background of mice is an important determinant of survival after CLP sepsis.
In animal models, potentiating adenosine's effects (by either administration of adenosine receptor agonists or by inhibition of adenosine enzyme pathways to limit rephosphorylation or prevent degradation) has been shown to improve outcomes in sepsis (1, 8, 14, 41, 48) . Use of AR KO mice further complements these prior studies. However, since compensatory physiological changes are inherent concerns with studies using KO mice, we also used a selective A 3 AR antagonist to illustrate that the results we observed in our A 3 AR KO mice can be demonstrated in A 3 AR WT mice treated with an A 3 AR antagonist. By using both models, we provide conclusive data that endogenous A 3 AR activation serves protective functions in CLP-induced sepsis.
We adopted the CLP model to more accurately recapitulate the complex immunology seen in human sepsis. Unlike models employing endotoxin or bacteria, this model induces septic peritonitis that more closely resembles human sepsis with regard to proinflammatory cytokine generation, progression to multiorgan injury and failure, and response to certain therapeutic interventions (44) . Another advantage of this septic model is the ability to manipulate the magnitude of the inflammatory response by modulating the needle size used for puncture. We employed a 22-or 20-gauge needle to induce in our mice a level of sepsis with moderate predilection for mortality and organ injury in the absence of any interventions. We demonstrate that the 22-gauge needle produces a milder form of sepsis with less mortality, organ dysfunction, and inflammation. However, in both needle size-induced CLP sepsis, A 3 AR activation improved and A 3 AR antagonist worsened mortality, organ dysfunction, and inflammation, respectively.
With CLP, cecal ischemia produces deterioration of mucosal integrity leading to bacterial translocation into the peritoneum as well as into the systemic circulation. Several studies demonstrated that bacterial translocation is an important initiating mechanism for the induction of systemic inflammation and organ injury after CLP as removal of the cecal contents or treatment with powerful antibiotics reduce mortality and organ dysfunction (12, 13) . We showed in the present study that high bacterial counts were observed in blood and peritoneal cavity (Fig. 5 ) 24 h after CLP sepsis. In particular, the A 3 AR KO mice subjected to 22-gauge CLP sepsis showed higher peritoneal bacterial counts compared with the A 3 AR WT mice. We believe that the lack of anti-inflammatory A 3 ARs led to higher bacterial counts in the peritoneum of A 3 AR KO mice, reflecting a state of more severe sepsis (higher mortality and renal and hepatic injury). Subjecting mice to more severe sepsis (20-gauge CLP) led to significantly increased bacterial counts in the peritoneum in all groups of mice. Interestingly, A 3 AR modulation had no impact on blood bacterial counts and a similar degree of bacteremia was observed between mice subjected to 22-and 20-gauge CLP. Therefore, the mechanism(s) of bacterial translocation may be different between the peritoneum and the blood.
Given that our central goal was to evaluate the effect of endogenous A 3 AR activation on outcomes in murine sepsis, we chose not to possibly confound our results by introducing antibiotics into our studies. We recognize that antibiotics themselves have therapeutic value. In fact, we were able to demonstrate differences in survival and morbidity without having to manipulate survival outcomes with antibiotic administration. However, we did give fluid resuscitation to produce and mimic hemodynamic changes seen during early (hyperdynamic) sepsis. We show that the bacterial load of blood and peritoneum did not differ between A 3 AR WT mice, A 3 AR WT mice treated with IB-MECA, and A 3 AR KO mice subjected to 20-gauge CLP sepsis, indicating that the modulation of survival, and renal and hepatic function is not impacted by bacterial contamination after CLP sepsis. Rather, potent antiinflammatory effects of A 3 AR activation may directly produce survival and organ function preservation in mice treated with an A 3 AR agonist (IB-MECA).
Sepsis represents a systemic inflammatory response that initially manifests as an overproduction of stimulatory mediators including proinflammatory cytokines (i.e., TNF-␣), and chemokines (i.e., KC). In the present study, the inflammatory processes elicited during CLP-induced sepsis contributed to a greater organ injury and dysfunction observed in A 3 AR KO mice because they do not possess the counterbalancing antiinflammatory benefits afforded by endogenous A 3 AR activation. This is supported by the findings that TNF-␣ and KC levels increased in the plasma by 24 h following CLP; however, these cytokine levels in A 3 AR KO mice were significantly elevated compared with A 3 WT mice. Murine KC is a proinflammatory chemokine that putatively represents the functional homologue of human IL-8. As such, KC not only serves as a potent neutrophil attractant and activator, but its overexpression has also been associated with various inflammatory conditions and is a marker for increased mortality in the CLP sepsis model (22) .
Previous studies suggested that IL-6 serves as both a marker and a mediator for the severity of sepsis (45) . Our study also supports these findings in that more severe sepsis induced with a 20-gauge needle resulted in higher plasma levels of IL-6 compared with plasma levels after CLP with a 22-gauge needle (Table 2) . However, unlike plasma TNF-␣ and KC levels, modulation of A 3 ARs failed to have an impact on plasma IL-6 levels because we found no significant differences in IL-6 levels between A 3 AR WT mice, A 3 AR KO mice, and A 3 AR WT mice treated with IB-MECA. Recent studies also propose an important role for the production of anti-inflammatory mediators, such as IL-10 for the modulation of the septic response (27, 33) . We demonstrate in this study that A 3 AR KO mice with a more severe septic injury showed higher plasma levels of IL-10 mice, perhaps indicating an increased endogenous anti-inflammatory response against the more severe septic response ( Table 2 ). The A 3 AR activation failed to modulate plasma IL-10 levels. In addition, as the mortality rate for the A 3 AR KO mice was higher compared with the A 3 AR WT mice, we conclude that plasma IL-10 levels did not modulate survival after CLP sepsis in these mice. Taken together, IL-6 or IL-10 modulation is not a major mechanism of A 3 AR-mediated protection against CLP sepsis.
Generation of cytokines and LPS during sepsis leads to toll receptor activation and propagation of the pathogenesis of sepsis. A central downstream element of toll receptor-dependent signaling is activation of the pleiotropic transcription factor NF-B. NF-B has been implicated in the regulation of multiple biological phenomena and disease states, including apoptosis, cell growth, stress response, innate immunity, and septic shock. Studies have demonstrated that increased NF-B expression is predictive of poor prognosis in sepsis (5) . In other models of sepsis, suppression of NF-B activation decreased acute inflammatory processes and organ dysfunction (35) . Further evidence for the anti-inflammatory role of endogenous A 3 AR activation in sepsis is demonstrated in the present study by the significant increase in activation of NF-B shown in A 3 KO KO mice compared with A 3 WT mice in response to sepsis that underscores the potential signaling pathways by which A 3 AR may be exerting its protective effects in sepsis.
The two major limitations of this study are that 1) the cell type(s) involved in protection against CLP sepsis and 2) the signal transduction mechanism(s) after activation of A 3 AR leading to anti-inflammatory and protective effects are not elucidated. Multiple immune, as well as nonimmune, cells play an intricate role in defending against septic pathogenesis including macrophages, lymphocytes, as well as, neutrophils in several organs including spleen, liver, and thymus. Several of these cell types may be involved in the in vivo protective effects of IB-MECA because the presence of A 3 ARs in these cell types has been demonstrated (25) . In particular, A 3 AR activation produces anti-inflammatory effects in monocyte/ macrophage cell lines (20, 25) .
In conclusion, we demonstrate that endogenous or exogenous A 3 AR activation provides protection from CLP-induced mortality and acute organ dysfunction. Since the pathogenesis of organ dysfunction in sepsis is largely mediated by an imbalanced inflammatory response, A 3 AR activation improves organ function after septic insult by attenuating this hyperinflammatory process. Given the protective benefit of the A 3 AR on survival and organ dysfunction, our findings may have important future therapeutic implications for patients in sepsis.
